このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Sinocare 将来の成長

Future 基準チェック /36

Sinocare利益と収益がそれぞれ年間26.4%と13%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に14.5% 25.9%なると予測されています。

主要情報

26.4%

収益成長率

25.9%

EPS成長率

Medical Equipment 収益成長	22.4%
収益成長率	13.0%
将来の株主資本利益率	14.5%
アナリストカバレッジ	Low
最終更新日	23 May 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

SZSE:300298 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	5,945	653	N/A	753	3
12/31/2025	5,369	560	N/A	644	5
12/31/2024	4,618	433	N/A	582	4
3/31/2024	4,190	306	303	657	N/A
12/31/2023	4,059	284	389	735	N/A
9/30/2023	4,361	371	224	564	N/A
6/30/2023	4,334	384	453	741	N/A
3/31/2023	4,215	441	434	760	N/A
1/1/2023	3,952	447	362	682	N/A
9/30/2022	3,463	296	485	803	N/A
6/30/2022	3,081	218	258	610	N/A
3/31/2022	2,478	128	171	475	N/A
1/1/2022	2,361	108	76	480	N/A
9/30/2021	2,235	134	-58	366	N/A
6/30/2021	2,174	147	-22	365	N/A
3/31/2021	2,095	168	28	435	N/A
12/31/2020	2,015	187	229	505	N/A
9/30/2020	2,049	287	324	566	N/A
6/30/2020	1,936	280	245	502	N/A
3/31/2020	1,831	265	273	517	N/A
12/31/2019	1,778	251	101	523	N/A
9/30/2019	1,651	286	-26	474	N/A
6/30/2019	1,604	272	66	534	N/A
3/31/2019	1,607	276	-72	368	N/A
12/31/2018	1,551	310	77	319	N/A
9/30/2018	1,429	286	-22	116	N/A
6/30/2018	1,301	333	-48	59	N/A
3/31/2018	1,112	296	57	158	N/A
1/1/2018	1,033	258	N/A	244	N/A
9/30/2017	994	206	N/A	270	N/A
6/30/2017	945	156	N/A	272	N/A
3/31/2017	849	116	N/A	223	N/A
12/31/2016	796	115	N/A	203	N/A
9/30/2016	722	138	N/A	231	N/A
6/30/2016	674	121	N/A	180	N/A
3/31/2016	698	155	N/A	183	N/A
12/31/2015	646	144	N/A	122	N/A
9/30/2015	634	176	N/A	164	N/A
6/30/2015	611	191	N/A	170	N/A
3/31/2015	570	199	N/A	147	N/A
12/31/2014	545	197	N/A	153	N/A
9/30/2014	506	191	N/A	131	N/A
6/30/2014	488	176	N/A	133	N/A
3/31/2014	450	157	N/A	128	N/A
12/31/2013	449	165	N/A	114	N/A
9/30/2013	429	156	N/A	121	N/A
6/30/2013	387	139	N/A	103	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 300298の予測収益成長率 (年間26.4% ) は貯蓄率 ( 2.9% ) を上回っています。

収益対市場: 300298の収益 ( 26.4% ) はCN市場 ( 22.7% ) よりも速いペースで成長すると予測されています。

高成長収益: 300298の収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: 300298の収益 ( 13% ) CN市場 ( 13.9% ) よりも低い成長が予測されています。

高い収益成長: 300298の収益 ( 13% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 300298の自己資本利益率は、3年後には低くなると予測されています ( 14.5 %)。

Sinocare 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Price target decreased by 8.0% to CN¥31.01

Price target decreased by 14% to CN¥33.71

Price target increased to CN¥39.34

Consensus forecasts updated

Price target decreased to CN¥20.73

Price target decreased to CN¥40.66

Recent updates

Sinocare Inc. to Report First Half, 2024 Results on Aug 29, 2024

Sinocare Inc. Announces Dividend Implementation for 2023, Payable on 17 June 2024

Is Sinocare (SZSE:300298) A Risky Investment?

Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture

Price target decreased by 8.0% to CN¥31.01

Sinocare Inc., Annual General Meeting, May 21, 2024

Sinocare Inc. Proposes Final Dividend for 2023

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.12 in 1Q 2023)

Investor sentiment improves as stock rises 16%

Sinocare Inc.'s (SZSE:300298) P/E Is On The Mark

Now 21% undervalued after recent price drop

Here's What To Make Of Sinocare's (SZSE:300298) Decelerating Rates Of Return

Sinocare Inc. to Report Q1, 2024 Results on Apr 26, 2024

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Sinocare Inc. to Report Fiscal Year 2023 Results on Apr 26, 2024

Investor sentiment improves as stock rises 24%

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.28 in 3Q 2022)

Now 20% undervalued

Sinocare Inc. to Report Q3, 2023 Results on Oct 24, 2023

Now 20% undervalued after recent price drop

Price target decreased by 14% to CN¥33.71

Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.26 in 2Q 2022)

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Sinocare Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 26 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to CN¥39.34

Sinocare Inc. Approves Board Elections

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.13 in 2Q 2021)

Sinocare Inc. Approves Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Consensus forecasts updated

Price target decreased to CN¥20.73

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Sinocare Inc., Annual General Meeting, May 13, 2022

Sinocare Inc. Proposes Cash Dividend for 2021

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.16 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.17 in 2Q 2020)

Price target decreased to CN¥40.66

Consensus forecasts updated

First quarter 2021 earnings released: EPS CN¥0.079 (vs CN¥0.11 in 1Q 2020)

Investor sentiment deteriorated over the past week

New 90-day low: CN¥31.87

Sinocare Inc. to Report Fiscal Year 2020 Results on Apr 17, 2021

New 90-day high: CN¥46.30

Third quarter earnings released

Sinocare Inc. to Report Q3, 2020 Results on Oct 17, 2020

Earnings released

Sinocare Inc. to Report First Half, 2020 Results on Aug 07, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘